Vona Oncology
PrivateLast Round
Grant
Nov 20, 2025
Total Funding Raised
$2.89M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Vona Oncology is a biopharmaceutical company developing targeted therapeutics to treat aggressive cancers such as triple-negative breast cancer, ovarian cancer, and melanoma.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vona Oncology Comparables
Compare Vona Oncology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Raadysan Biotech | 86% | |
| Persevere Therapeutics | 78% | |
| Illumen Therapeutics Inc. | 77% |
Vona Oncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 20, 2025 | ||||
| Grant | May 20, 2021 |
Vona Oncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Colorado Office of Economic Development and International Trade | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 1095% MoM, reaching 2.7K.
- Dec 2, 2025
Monthly visitors increased 222% MoM.
Vona Oncology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Vona Oncology's valuation, stock price, and market status.
Is Vona Oncology a public or private company?
Vona Oncology is a private company.
What is the current stock price of Vona Oncology?
Vona Oncology is a private company with no public stock price. No recent secondary market data is available.
How much is Vona Oncology worth (valuation)?
Valuation information for Vona Oncology is not publicly available.
Can I buy Vona Oncology stock?
Vona Oncology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Vona Oncology's last funding round?
Vona Oncology's most recent funding round was Grant on November 20, 2025.
Who are the main investors in Vona Oncology?
Key investors in Vona Oncology include NIH RADx, Colorado Office of Economic Development and International Trade.
Will Vona Oncology IPO soon?
No public IPO plans have been announced for Vona Oncology.
How can I track Vona Oncology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vona Oncology's secondary market activity and sign up for updates.